{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:27:20Z","timestamp":1789950440422,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.leukres.2011.06.021","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T17:10:26Z","timestamp":1312909826000},"page":"1390-1394","source":"Crossref","is-referenced-by-count":76,"title":["ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"35","author":[{"given":"H. Elizabeth","family":"Broome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Z.","family":"Rassenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly M.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.leukres.2011.06.021_bib0005","doi-asserted-by":"crossref","first-page":"26181","DOI":"10.1016\/S0021-9258(18)35733-8","article-title":"A novel family of cell surface receptors with tyrosine kinase-like domain","volume":"267","author":"Masiakowski","year":"1992","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.leukres.2011.06.021_bib0010","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.0712148105","article-title":"Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a","volume":"105","author":"Fukuda","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.leukres.2011.06.021_bib0015","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.1073\/pnas.0903233106","article-title":"RNAi screen for rapid therapeutic target identification in leukemia patients","volume":"106","author":"Tyner","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.leukres.2011.06.021_bib0020","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2010-05-283309","article-title":"The B-cell tumor associated antigen ROR1 can be targeted with T-cells modified to express a ROR1-specific chimeric antigen receptor","volume":"116","author":"Hudecek","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.021_bib0025","first-page":"245","article-title":"Sternal marrow of children in normal and pathologic states","volume":"57","author":"Vogel","year":"1939","journal-title":"Am J Dis Child"},{"issue":"6","key":"10.1016\/j.leukres.2011.06.021_bib0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajcp\/95.6.816","article-title":"B-cell precursors in normal pediatric bone marrow","volume":"95","author":"Caldwell","year":"1991","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.leukres.2011.06.021_bib0035","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood.V98.8.2498","article-title":"Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry","volume":"98","author":"McKenna","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2011.06.021_bib0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ajcp\/102.2.202","article-title":"Hematogones in the bone marrow of adults. Immunophenotypic features, clinical settings, and differential diagnosis","volume":"102","author":"Davis","year":"1994","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.leukres.2011.06.021_bib0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1705714","article-title":"Expansion of B cell precursors after unrelated cord blood transplantation for an adult patient","volume":"40","author":"Mattei","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.leukres.2011.06.021_bib0050","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1158\/1078-0432.CCR-07-1823","article-title":"Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia","volume":"14","author":"Baskar","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.leukres.2011.06.021_bib0055","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ijc.23587","article-title":"ROR1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy","volume":"123","author":"Daneshmanesh","year":"2008","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2011.06.021_bib0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.leu.2401279","article-title":"Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL","volume":"13","author":"Lucio","year":"1999","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2011.06.021_bib0065","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood.V82.4.1086.1086","article-title":"Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study","volume":"82","author":"Borowitz","year":"1993","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2011.06.021_bib0070","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/eji.200939633","article-title":"Tolerance checkpoints in B-cell development: Johnny B good","volume":"39","author":"Tussiwand","year":"2009","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.leukres.2011.06.021_bib0075","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.4049\/jimmunol.181.6.3955","article-title":"Contrasting responses of lymphoid progenitors to canonical and noncanonical Wnt signals","volume":"181","author":"Malhotra","year":"2008","journal-title":"J Immunol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T02:22:55Z","timestamp":1638238975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611003067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0145212611003067"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.06.021","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}